Aprepitant when added to a standard antiemetic regimen consisting of ondansetron and dexamethasone does not affect vinorelbine pharmacokinetics in cancer patients

Walter Loos; Ronald de Wit; SJ Freedman; K Van Dyck; JJ Gambale; Shan Li; GM Murphy; CHC (Connie) van Noort; Peter de Bruijn; Jaap Verweij

doi:10.1007/s00280-006-0359-6

Aprepitant when added to a standard antiemetic regimen consisting of ondansetron and dexamethasone does not affect vinorelbine pharmacokinetics in cancer patients

Walter Loos, Ronald de Wit, SJ Freedman, K Van Dyck, JJ Gambale, Shan Li, GM Murphy, CHC (Connie) van Noort, Peter de Bruijn, Jaap Verweij

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

44 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	407-412
Number of pages	6
Journal	Cancer Chemotherapy & Pharmacology
Volume	59
Issue number	3
DOIs	https://doi.org/10.1007/s00280-006-0359-6
Publication status	Published - 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00280-006-0359-6

http://hdl.handle.net/1765/36125

Cite this

Loos, W., de Wit, R., Freedman, SJ., Van Dyck, K., Gambale, JJ., Li, S., Murphy, GM., van Noort, CHC., de Bruijn, P., & Verweij, J. (2007). Aprepitant when added to a standard antiemetic regimen consisting of ondansetron and dexamethasone does not affect vinorelbine pharmacokinetics in cancer patients. Cancer Chemotherapy & Pharmacology, 59(3), 407-412. https://doi.org/10.1007/s00280-006-0359-6

@article{2c49ec63653740a1b8ea144ef9ce6a5d,

title = "Aprepitant when added to a standard antiemetic regimen consisting of ondansetron and dexamethasone does not affect vinorelbine pharmacokinetics in cancer patients",

author = "Walter Loos and {de Wit}, Ronald and SJ Freedman and {Van Dyck}, K and JJ Gambale and Shan Li and GM Murphy and {van Noort}, {CHC (Connie)} and {de Bruijn}, Peter and Jaap Verweij",

year = "2007",

doi = "10.1007/s00280-006-0359-6",

language = "Undefined/Unknown",

volume = "59",

pages = "407--412",

journal = "Cancer Chemotherapy and Pharmacology",

issn = "0344-5704",

publisher = "Springer-Verlag",

number = "3",

}

Loos, W, de Wit, R, Freedman, SJ, Van Dyck, K, Gambale, JJ, Li, S, Murphy, GM, van Noort, CHC, de Bruijn, P & Verweij, J 2007, 'Aprepitant when added to a standard antiemetic regimen consisting of ondansetron and dexamethasone does not affect vinorelbine pharmacokinetics in cancer patients', Cancer Chemotherapy & Pharmacology, vol. 59, no. 3, pp. 407-412. https://doi.org/10.1007/s00280-006-0359-6

Aprepitant when added to a standard antiemetic regimen consisting of ondansetron and dexamethasone does not affect vinorelbine pharmacokinetics in cancer patients. / Loos, Walter; de Wit, Ronald; Freedman, SJ et al.
In: Cancer Chemotherapy & Pharmacology, Vol. 59, No. 3, 2007, p. 407-412.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Aprepitant when added to a standard antiemetic regimen consisting of ondansetron and dexamethasone does not affect vinorelbine pharmacokinetics in cancer patients

AU - Loos, Walter

AU - de Wit, Ronald

AU - Freedman, SJ

AU - Van Dyck, K

AU - Gambale, JJ

AU - Li, Shan

AU - Murphy, GM

AU - van Noort, CHC (Connie)

AU - de Bruijn, Peter

AU - Verweij, Jaap

PY - 2007

Y1 - 2007

U2 - 10.1007/s00280-006-0359-6

DO - 10.1007/s00280-006-0359-6

M3 - Article

SN - 0344-5704

VL - 59

SP - 407

EP - 412

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

IS - 3

ER -